Ovarian-cancer-data: Data originate from two clinical trials on the use of...

In dynpred: Companion Package to "Dynamic Prediction in Clinical Survival Analysis"

Description

A data frame of 358 patients with ovarian cancer. The included variables are

tyears

Time in years until death or last follow-up

d

Survival status; 1 = death; 0 = censored

Karn

Karnofsky score

Broders

Broders score: factor with levels "unknown", "1", "2", "3", "4"

FIGO

FIGO stage; factor with levels "III", "IV"

Ascites

Presence of ascires; factor with levels "unknown", "absent", "present"

Diam

Diameter of the tumor; factor with levels "micr.", "<1cm", "1-2cm", "2-5cm", ">5cm"

Format

A data frame, see data.frame.

References

Neijt, J. P., ten Bokkel Huinink, W. W., van der Burg, M. E., van Oosterom, A. T., Vriesendorp, R., Kooyman, C. D., van Lindert, A. C., Hamerlynck, J. V., van Lent, M. & van Houwelingen, J. C. (1984), 'Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP- 5) in advanced ovarian carcinoma', Lancet 2, 594–600.

Neijt, J. P., ten Bokkel Huinink, W. W., van der Burg, M. E., van Oosterom, A. T., Willemse, P. H., Heintz, A. P., van Lent, M., Trimbos, J. B., Bouma, J. & Vermorken, J. B. (1987), 'Randomized trial comparing two combination chemotherapy regimens (CHAP-5 vs CP) in advanced ovarian carcinoma', Journal of Clinical Oncology 5, 1157–1168.

van Houwelingen, J. C., ten Bokkel Huinink, W. W., van der Burg, M. E., van Oosterom, A. T. & Neijt, J. P. (1989), 'Predictability of the survival of patients with advanced ovarian cancer.', Journal of Clinical Oncology 7, 769–773.

dynpred documentation built on May 2, 2019, 5:07 a.m.